JB Chemicals & Pharmaceuticals to consider sub-division of equity shares
A final decision on this will be taken during the board meeting to be held on 24 May 202308-05-2023
08-05-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Intimation for Audited Financial Results For The Year And Quarter Ended On March 31, 2023, Recommendation Of Final Dividend On Equity Shares Of The Company, If Any, And Consideration And Approval Of The Proposal To Sub-Divide/Split The Equity Shares
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve audited financial results for the year and quarter ended on March 31, 2023, recommend final Dividend on equity shares of the Company, if any, and consider and approve the proposal to sub-divide/split the equity shares08-05-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyJ.B.CHEMICALS & PHARMACEUTICALS LTD. 2CIN NO.L24390MH1976PLC019380 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 521.38 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Sandeep Phadnis Designation: Vice President Secretarial and Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Lakshay Kataria Designation: Chief Financial Officer EmailId: [email protected] Date: 30/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.30-04-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Financial Year 2022-23
Certificate under Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for financial year 2022-2318-04-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliance Certificate Under Regulation 7(3) For The Year Ended March 31, 2023
Compliance certificate under regulation 7(3) for the year ended March 31, 202318-04-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 201813-04-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Closure of Trading Window
Closure of Trading Window31-03-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of letter of confirmation for duplicate share certificates - Intimation under regulation 39(3) the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 201530-03-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme02-03-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Transcript of Investors/Analysts call13-02-2023